Products and addictions
Drugs and addictive behaviours represent many major public health and security issues, whether it is a matter of preventing health and social harm or combatting trafficking.
Drugs and Addictions, Key Data (2022 edition) brings together the most recent statistical indicators to quantify and describe the phenomenon of psychoactive substance use (psychotropics drugs and medicines) and addiction in France. This 8-page document is based on the work of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) and other data-producing organisations.
For a more complete view, each product or addictive behaviour is further described below in a factsheet organised by issues (Production/supply, Use, Perceptions/opinions, Legal framework and recent public policies). See below:
Also a 2019 overview summarises the situation in France, relying on evidence-based data and outlining the most recent developments at the time: Drugs and Drug Addictions : Recent Trends and Perspectives.
Drugs in Europe
2021 EMCDDA European Drug Report
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
